ReviewAmerican journal of clinical dermatology2022
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.
Review in American journal of clinical dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
57 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies.The Australasian journal of dermatology · 2025Pooled it
- Glucocorticoids: an enemy or a friend for the dermatologist? recommendations for proper use and safe discontinuation.Endocrine · 2026Review
- Prompt recurrence of granuloma annulare upon Janus kinase inhibitor discontinuation.JAAD case reports · 2026Article
- Dermatologic Toxicities Induced by JAK Inhibitors.American journal of clinical dermatology · 2026Review
- Granuloma annulare treated with ivermectin.JAAD case reports · 2026Article
- Patch-type granuloma annulare mimicking bruises in a 9-year-old girl: first pediatric case report and literature review.BMC pediatrics · 2026Review
- Localized granuloma annulare successfully treated with ruxolitinib.JAAD case reports · 2026Article
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology.Medicina (Kaunas, Lithuania) · 2026Review
- Cutaneous Tuberculosis in the Modern Era: A Case of Lupus Vulgaris with Surgical Management and a Review of Clinical Spectrum, Diagnostic Challenges, and Malignant Potential.Journal of clinical medicine · 2026Article
- A novel pathogenic variant in PSTPIP1 highlights the diversity of PSTPIP1-associated disorders.Rheumatology (Oxford, England) · 2026Article
- Article
- Clinical and Histopathological Characteristics of Granuloma Annulare: Significance of Giant Cells and Systemic Inflammatory Markers.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- Article
- Excision and Regional Flap Reconstruction with Radiation Therapy of Granuloma Annulare of the Digit: A Case Report.Archives of plastic surgery · 2025Article
- Granuloma annulare after starting semaglutide.JAAD case reports · 2025Article
- Generalized granuloma annulare successfully treated with deucravacitinib (Sotyktu).JAAD case reports · 2025Article
- Perforating Granuloma Annulare with Cysts and Comedones.Dermatopathology (Basel, Switzerland) · 2025Article
- Article
- Granuloma annulare following acetazolamide challenge/rechallenge in a patient with idiopathic intracranial hypertension.JAAD case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Granuloma annulare (GA) is an inflammatory granulomatous skin disease that can be localized (localized GA) or disseminated (generalized GA), with patch, perforating, and subcutaneous subtypes being less common variants of this benign condition. Recently, new research has emerged that further elucidates GA epidemiology and etiopathogenesis; importantly, new therapeutic options for GA have also been described, although there remains a paucity of randomized controlled studies. In this review, we summarize recent updates on GA epidemiology and etiopathogenesis and offer an updated review of the therapeutic options for GA currently reported in the literature. We hope that the current review galvanizes randomized controlled studies that will in turn help lead to the recommendation of evidence-based treatments for GA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.